^○Di Comite Gabriele¹, Bar-or Amit², Weinstock-guttman Bianca³, Mao-draayer Yang⁴, Cox Gina⁵, Cruz Linda-ali⁵, Meng Xiangyi⁵, Su Wendy⁵, Cohan L. Stanley⁶ (1.Novartis Pharma KK, Tokyo, Japan, 2.Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, 3.Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA, 4.Autoimmunity Center of Excellence, Multiple Sclerosis Center, University of Michigan, Ann Arbor, MI, USA, 5.Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 6.Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, USA)

^○村井 弘之¹, Vera Bril², Tuan Vu³, Chafic Karam⁴, Stojan Peric⁵, 今井 富裕⁶, 高橋 正紀⁷, 鵜沢 顕之⁸, Antonio Guglietta⁹, Peter Ulrichts⁹, Tony Vangeneugden⁹, 槍沢 公明¹⁰, Renato Mantegazza¹¹, James F. Howard¹² (1.国際医療福祉大学, 2.Krembil Neuroscience Centre, 3.University of South Florida, 4.Hospital of the University of Pennsylvania, 5.Wroclaw Medical University, 6.札幌医科大学, 7.大阪大学, 8.千葉大学, 9.アルジェニクス, 10.総合花巻病院, 11.Fondazione Istituto Neurologico Carlo Besta, 12.The University of North Carolina)

^○Xichen Zhu^1,2, Tao Ma^1,2 (1.Department of Neurology, the Affiliated WuXi NO.2 People's Hospital of Nanjing Medical University, Wuxi, China, 2.Department of Neurology, WuXi NO.2 People's Hospital, Affiliated Wuxi Clinical College of of Nantong University, Wuxi, China)

^○真先 敏弘¹, Anura Rambukkana² (1.帝京科学大学医学教育センター, 2.エディンバラ大学再生医学センター)

^○荒木 学¹, Jacqueline Palace², Ingo Kleiter³, Anthony Traboulsee⁴, Takashi Yamamura⁵, Francesco Patti⁶, Daniela Stokmaier⁷, Gaelle Klingelschmitt⁷, Thomas Kuenzel⁷, H.-christian Von Büdingen⁷, Jeffrey L Bennett⁸ (1.Kawakita General Hospital, Tokyo, Japan, 2.John Radcliffe Hospital, Oxford, United Kingdom, 3.Ruhr University Bochum, Bochum, Germany, 4.University of British Columbia, Vancouver, Canada, 5.National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 6.University of Catania, Catania, Italy, 7.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 8.University of Colorado School of Medicine, Aurora, CO, USA)

^○Sunfa Cheng¹, Hirata Koichi², Takeshima Takao³, Sakai Fumihiko⁴, Imai Noboru⁵, Matsumori Yasuhiko⁶, Tatsuoka Yoshihisa⁷, Yoshida Ryuji⁸, Peng Cheng⁹, Mikol D.. Daniel¹ (1.Global Development, Amgen Inc., Thousand Oaks, CA, USA, 2.Headache Center, Department of Neurology, Dokkyo Medical University, 3.Headache Center, Department of Neurology, Tominaga Hospital, 4.Saitama International Headache Center, 5.Department of Neurology, Japanese Red Cross Shizuoka Hospital, 6.Sendai Headache and Neurology Clinic, 7.Department of Neurology, Tatsuoka Neurology Clinic, 8.Research & Development, Amgen K.K., 9.Global Biostatistical Science, Amgen Inc.)